EUVIMEDEUVIMED entdecken
Crossref

Reliability of roadside oral fluid testing devices for ∆ 9 ‐tetrahydrocannabinol (∆ 9 ‐THC) detection

Juliana Nichterwitz Scherer, Mailton Vasconcelos, Carolina Silveira Dalanhol, Bruna Govoni iD, Bruno Pereira Dos Santos iD, Gabriela Ramos Borges, Giovanna Cristiano de Gouveia, Patrícia Pacheco Viola iD, Renato Luiz Romera Carlson, Aline Franco Martins, Jose Luiz Costa, Marilyn A Huestis iD und 1 weitere

Drug Testing and Analysis · 2024

DOI: 10.1002/dta.3669 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Testing and Analysis, 2024. Verfasst von Juliana Nichterwitz Scherer und 12 weiteren Autor:innen. Beteiligte Einrichtung: Center for Drug and Alcohol Research, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, Brazil. Hauptthemen laut MEDLINE: Dronabinol, Saliva, Substance Abuse Detection, Tandem Mass Spectrometry. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Brazilian National Secretariat of Drug Polices.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Driving under the influence of cannabis (DUIC) is increasing worldwide, and cannabis is the most prevalent drug after alcohol in impaired driving cases, emphasizing the need for a reliable traffic enforcement strategy. ∆ 9 ‐tetrahydrocannabinol (THC) detection in oral fluid has great potential for identifying recent cannabis use; however, additional data are needed on the sensitivities, specificities, and efficiencies of different oral fluid devices for detecting cannabinoids at the roadside by police during routine traffic safety enforcement efforts. At the roadside, 8945 oral fluid THC screening tests were performed with four devices: AquilaScan®, Dräger DrugTest®, WipeAlyser Reader®, and Druglizer®. A total of 530 samples screened positive for THC (5.9%) and were analyzed by liquid chromatography–tandem mass spectrometry at multiple cutoff concentrations (2 ng/mL, 10 ng/mL, and manufacturers' recommended device cutoffs) to investigate device performance. Results varied substantially, with sensitivities of 0%–96.8%, specificities of 89.8%–98.5%, and efficiencies of 84.3%–97.8%. The Dräger DrugTest® outperformed the other devices with a 96.8% sensitivity, 97.1% specificity, and 97.0% efficiency at a 5‐ng/mL LC–MS/MS confirmation cutoff. The WipeAlyser Reader® had good performance with a 91.4% sensitivity, 97.2% specificity, and 96.4% efficiency. AquilaScan® and Druglizer® had unacceptable performance for cannabinoid detection, highlighted by sensitivity

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DronabinolSalivaSubstance Abuse DetectionTandem Mass SpectrometryDriving Under the InfluenceSensitivity and SpecificityHumansChromatography, LiquidReproducibility of ResultsAutomobile Driving

Stichwörter der Autor:innen

driving under the influence of cannabis (DUIC)oral fluidroadside drug testing∆9‐tetrahydrocannabinol

Substanzen

Dronabinol

Autor:innen und Institutionen

  • Center for Drug and Alcohol Research, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, Brazil.
  • Programa de Pós-Graduação em Saúde Coletiva, Universidade do Vale do Rio dos Sinos (UNISINOS), São Leopoldo, Brazil.
  • Graduate Program in Health Sciences, Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre, Brazil.
  • Campinas Poison Control Center, University of Campinas (UNICAMP), Campinas, Brazil.
  • Faculty of Pharmaceutical Sciences, University of Campinas (UNICAMP), Campinas, Brazil.
  • Institute of Emerging Health Professions, Thomas Jefferson University, Severna Park, Maryland, USA.

ORCID-Profile: Bruna Govoni, Bruno Pereira Dos Santos, Patrícia Pacheco Viola, Marilyn A Huestis

Förderung

  • Brazilian National Secretariat of Drug Polices

Zitieren

APA

Scherer, J. N., Vasconcelos, M., Dalanhol, C. S., Govoni, B., Dos Santos, B. P., Borges, G. R., de Gouveia, G. C., Viola, P. P., Carlson, R. L. R., Martins, A. F., Costa, J. L., Huestis, M. A., & Pechansky, F. (2024). Reliability of roadside oral fluid testing devices for ∆ 9 ‐tetrahydrocannabinol (∆ 9 ‐THC) detection. Drug Testing and Analysis. https://doi.org/10.1002/dta.3669

Vancouver

Scherer JN, Vasconcelos M, Dalanhol CS, Govoni B, Dos Santos BP, Borges GR, et al. Reliability of roadside oral fluid testing devices for ∆ 9 ‐tetrahydrocannabinol (∆ 9 ‐THC) detection. Drug Testing and Analysis. 2024. doi:10.1002/dta.3669

BibTeX
@article{Scherer2024,
  author = {Scherer, Juliana Nichterwitz and Vasconcelos, Mailton and Dalanhol, Carolina Silveira and Govoni, Bruna and Dos Santos, Bruno Pereira and Borges, Gabriela Ramos and de Gouveia, Giovanna Cristiano and Viola, Patrícia Pacheco and Carlson, Renato Luiz Romera and Martins, Aline Franco and Costa, Jose Luiz and Huestis, Marilyn A and Pechansky, Flavio},
  title = {Reliability of roadside oral fluid testing devices for ∆ 9 ‐tetrahydrocannabinol (∆ 9 ‐THC) detection},
  journal = {Drug Testing and Analysis},
  year = {2024},
  doi = {10.1002/dta.3669}
}
Kostenlos starten →